Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到14条与Standard有关的结果

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Clinical Practice Guideline for Stage Ⅳ Primary Lung Cancer in China(2021 Version)

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第1期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists and Medical Oncology Branch of Chinese International Exchange Promotion Association for Medical and Healthcare

Diagnosis Lung Neoplasms Standard Therapy.
指南简介 原文链接
Clinical Practice Guideline for Brain Metastases of Lung Cancer in China (2021 Version)

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

Brain Metastases Lung Neoplasms Standard Therapy.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Standards

2020年发布于 Cancer 126卷第11期 所属人体系统：其他 | 腹膜肿瘤

Chicago Consensus Working Group

Consensus Neoplasm Metastasis Peritoneal Neoplasms Standard of Care.
指南简介 原文链接
Cancer Oligometastases Heterogeneity: Standardizing Nomenclature. in Regard to Defining Oligometastatic Disease from a Radiation Oncology Perspective: an ESTRO-ASTRO Consensus Document

2020年发布于 Radiotherapy and Oncology 149卷第期 所属人体系统：其他 | 寡转移性疾病

European Society for Radiotherapy and Oncology American Society for Radiation Oncology

Cancer Oligometastases Heterogeneity Standardizing Nomenclature Consensus
指南简介 原文链接
Standardized Management Guideline for Pediatric Wards of Hematology and Oncology During the Epidemic of Coronavirus Disease 2019

2020年发布于 Zhongguo Dang Dai Er Ke Za Zhi 22卷第3期 所属人体系统：循环 | 血液肿瘤

Subspecialty Group of Hematology and Oncology Society of Pediatrics of Hubei

Hematology Oncology Pediatric Wards Standardized Management Guideline
指南简介 原文链接
European Consensus on the Standardization of Robotic Total Mesorectal Excision for Rectal Cancer

2019年发布于 Colorectal Disease 21卷第3期 所属人体系统：消化 | 直肠癌

无

Consensus Rectal Cancer Robotic Surgery Technical Standard.
指南简介 原文链接
European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update

2019年发布于 Eur Urol 75卷第5期 所属人体系统：泌尿 | 肾癌

European Association of Urology

The European Association of Urology Renal Cell Carcinoma Guideline Panel Has Thoroughly Evaluated the Available Research Data on Kidney Cancer to Establish International Standards for the Care of Kidney Cancer Patients
指南简介 原文链接
Joint EANM/EANO/RANO Practice Guidelines/SNMMI Procedure Standards for Imaging of Gliomas Using PET with Radiolabelled Amino Acids and [(18)F]FDG: Version 1.0

2019年发布于 Eur J Nucl Med Mol Imaging 46卷第3期 所属人体系统：神经 | 胶质细胞瘤

European Association of Nuclear Medicine Society of Nuclear Medicine and Molecular Imaging European Association of Neurooncology Working Group for Response Assessment in Neurooncology with PET

FDG FDOPA FET Glioma MET PET Procedure Standard Guideline
指南简介 原文链接
AIEOP-BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

2018年发布于 Cytometry B Clin Cytom 94卷第1期 所属人体系统：循环 | 白血病

AIEOP-BFM

Flow Cytometry Immunophenotyping: Leukemia Pediatric Standardization
指南简介 原文链接
Chinese Association of Ultrasound in Medicine and Engineering, Superficial Organs and Peripheral Vessels Committee Expert Consensus on Clinical Frequently Asked Questions in Breast Ultrasonography, June 2018

2018年发布于 J Cancer Res Ther 14卷第7期 所属人体系统：生殖 | 乳腺肿瘤

Chinese Association of Ultrasound in Medicine and Engineering Superficial Organs and Peripheral Vessels Committee Expert

Ultrasonography the Preferred Imaging Modality for Breast Diseases Has Merits Such as Absence of Radiation High Diagnostic Accuracy and Convenience for Follow-up Thus Playing an Important Role in Clinical Diagnosis and Management the American College of Radiology (ACR) Proposed Breast Imaging-Reporting and Data System (BI-RADS ) and Has Updated for Several Times Gradually the BI-RADS Has Been Accepted and Adopted by Ultrasound Physicians at All Levels of Hospitals in China and It Has Played a Certain Role in Improving the Diagnostic Level of Breast Ultrasound in China in Order to Standardize Breast Ultrasound Application and Raise the Status of Ultrasound in Clinical Decision-making of Breast Diseases Based on the Latest Edition of ACR BI-RADS Atlas 2013 the Committee Has Reached the "Expert Consensus on Clinical Frequently Asked Questions in Breast Ultrasonography"on a Number of Controversial Frequently Asked Questions (FAQs) in Clinical Practice (hereafter Referred to as "Consensus") and Will Be Dedicated to Updating the Contents of the "Consensus" Through Further Experience in Clinical Practice and the Advent of New Information from Further Studies This Consensus Is Only for Reference Purposes for Medical Personnel and the Processes Outlined Are Not Mandatory by Law
指南简介 原文链接
Magnetic Resonance Imaging for Clinical Management of Rectal Cancer: Updated Recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Consensus Meeting (vol 28, Pg 1465, 2017)

2018年发布于 Eur Radiol 28卷第4期 所属人体系统：消化 | 直肠癌

European Society of Gastrointestinal and Abdominal Radiology

Magnetic Resonance Imaging Cancer Rectal Neoplasms Standards Staging Structured Reporting
指南简介 原文链接

人体系统

共搜索到14条 与Standard有关的结果

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

2021年 发布于 Zhonghua Zhong Liu Za Zhi 43卷 第1期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists and Medical Oncology Branch of Chinese International Exchange Promotion Association for Medical and Healthcare

2021年 发布于 Zhonghua Zhong Liu Za Zhi 43卷 第3期 所属人体系统： 呼吸 | 肺癌

Chinese Association for Clinical Oncologists Medical Oncology Branch of Chinese International Exchange and Promotion Association for Medical and Healthcare

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

2020年 发布于 Cancer 126卷 第11期 所属人体系统： 其他 | 腹膜肿瘤

Chicago Consensus Working Group

2020年 发布于 Radiotherapy and Oncology 149卷 第期 所属人体系统： 其他 | 寡转移性疾病

European Society for Radiotherapy and Oncology American Society for Radiation Oncology

2020年 发布于 Zhongguo Dang Dai Er Ke Za Zhi 22卷 第3期 所属人体系统： 循环 | 血液肿瘤

Subspecialty Group of Hematology and Oncology Society of Pediatrics of Hubei

2019年 发布于 Colorectal Disease 21卷 第3期 所属人体系统： 消化 | 直肠癌

无

2019年 发布于 Eur Urol 75卷 第5期 所属人体系统： 泌尿 | 肾癌

European Association of Urology

2019年 发布于 Eur J Nucl Med Mol Imaging 46卷 第3期 所属人体系统： 神经 | 胶质细胞瘤

European Association of Nuclear Medicine Society of Nuclear Medicine and Molecular Imaging European Association of Neurooncology Working Group for Response Assessment in Neurooncology with PET

2018年 发布于 Cytometry B Clin Cytom 94卷 第1期 所属人体系统： 循环 | 白血病

AIEOP-BFM

2018年 发布于 J Cancer Res Ther 14卷 第7期 所属人体系统： 生殖 | 乳腺肿瘤

Chinese Association of Ultrasound in Medicine and Engineering Superficial Organs and Peripheral Vessels Committee Expert

2018年 发布于 Eur Radiol 28卷 第4期 所属人体系统： 消化 | 直肠癌

European Society of Gastrointestinal and Abdominal Radiology

共搜索到14条与Standard有关的结果

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第1期 所属人体系统：呼吸 | 肺癌

2021年发布于 Zhonghua Zhong Liu Za Zhi 43卷第3期 所属人体系统：呼吸 | 肺癌

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 Cancer 126卷第11期 所属人体系统：其他 | 腹膜肿瘤

2020年发布于 Radiotherapy and Oncology 149卷第期 所属人体系统：其他 | 寡转移性疾病

2020年发布于 Zhongguo Dang Dai Er Ke Za Zhi 22卷第3期 所属人体系统：循环 | 血液肿瘤

2019年发布于 Colorectal Disease 21卷第3期 所属人体系统：消化 | 直肠癌

2019年发布于 Eur Urol 75卷第5期 所属人体系统：泌尿 | 肾癌

2019年发布于 Eur J Nucl Med Mol Imaging 46卷第3期 所属人体系统：神经 | 胶质细胞瘤

2018年发布于 Cytometry B Clin Cytom 94卷第1期 所属人体系统：循环 | 白血病

2018年发布于 J Cancer Res Ther 14卷第7期 所属人体系统：生殖 | 乳腺肿瘤

2018年发布于 Eur Radiol 28卷第4期 所属人体系统：消化 | 直肠癌